Discovery of a novel Nav1.5 inhibitor reducing cardiac conduction via structure-based virtual screening and assays

Key Result

The novel Nav1.5 inhibitor significantly reduced cardiac conduction in assays, indicating its potential therapeutic role in cardiac arrhythmias.

Key Points

• This research aims to identify a new inhibitor of Nav1.5 that can effectively reduce cardiac conduction.
• Utilized structure-based virtual screening to identify potential Nav1.5 inhibitors.
• Conducted various assays to evaluate the efficacy of the identified inhibitors.
• Analyzed the impact on cardiac conduction pathways.
• Identified a novel inhibitor that significantly reduced cardiac conduction.
• Demonstrated improved binding affinity to Nav1.5 compared to existing treatments.
• Observed clear dose-dependent effects on conduction rates.